SiRNA in Drug Discovery & Development, La Jolla, CA, USA
Event Mar 24
Small interference RNAs (siRNAs) have gained a lot of attention in drug discovery and development due to their powerful ability in selective gene silencing. As promising as the technology is, it’s critical and never too early to discuss and address the business aspects. How will the big pharmaceutical companies integrate and utilize the technology in accelerating drug development? How shall smaller biotech companies specialized in siRNAs make creative deals and partnerships? What are the bottlenecks in realizing the commercial value? How are the prospects of siRNAs as new therapeutics compared to other RNA therapeutics, a powerful tool in target identification and validation? What are the market prospect and trends for the siRNA industry?
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018